X T L Bio

XTLB NASDAQ
1.950
0.000
0.00%
已收盘, 16:00 07/22 EDT
开盘
--
昨收
2.055
最高
--
最低
--
成交量
61
成交均量(3M)
1,494
52周最高
3.855
52周最低
1.430
换手率
0%
市值
905.81万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供X T L Bio XTLB股票价格,X T L Bio股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
展开 >

最近浏览

名称
价格
涨跌幅